SCIDEV LIMITED (SDV)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

SDV - SCIDEV LIMITED

Year End: June
GICS Industry Group : NONE
Debt/EBITDA: 0.88
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.595

07 Oct
2024

-0.015

OPEN

$0.61

-2.46%

HIGH

$0.61

199

LOW

$0.60

OTHER COMPANIES IN THE SAME SECTOR
3DA . ALQ . AVD . BSA . CG1 . CLG . CVL . CWY . CXL . DOW . DUR . EGN . EVS . FLC . IPG . LBL . MAD . PPK . SHA . SND . SSM . VEE . VNT .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx1.2
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx109.1 M
Book Value Per Share xxxxxxxxxxxxxxx26.5
Net Operating Cash Flow xxxxxxxxxxxxxxx6.5 M
Net Profit Margin xxxxxxxxxxxxxxx1.99 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx4.43 %
Return on Invested Capital xxxxxxxxxxxxxxx4.25 %
Return on Assets xxxxxxxxxxxxxxx3.12 %
Return on Equity xxxxxxxxxxxxxxx4.43 %
Return on Total Capital xxxxxxxxxxxxxxx8.80 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx4.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx3 M
Long Term Debt xxxxxxxxxxxxxxx2 M
Total Debt xxxxxxxxxxxxxxx5 M
Goodwill - Gross xxxxxxxxxxxxxxx21 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx9 M
Price To Book Value xxxxxxxxxxxxxxx1.40

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx2.1 M
Capex % of Sales xxxxxxxxxxxxxxx1.89 %
Cost of Goods Sold xxxxxxxxxxxxxxx98 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx7 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

29/07/2024

1

Upgrade to Buy from Speculative Buy

$0.68

14.29%

SciDev's June-quarter report sharply outpaced Canaccord Genuity's forecasts leading to a 2% beat on the broker's FY24 revenue forecasts.

Earnings (EBITDA) proved a miss as did operating cash flow.

Free cash flow proved a strong beat and the company closed June 30 with a cash balance of $9.4m (the broker forecast $6.7m) with no debt, thanks in part to less capital expenditure and reduced earnout, observes the broker.

Canaccord Genuity forecasts a strong September given tender activity and secured pipeline. EPS forecasts rise 5% for FY25.

Rating is upgraded to Buy from Speculative Buy. Target price rises to 68c from 54c.

FORECAST
Canaccord Genuity forecasts a full year FY24 dividend of 0.00 cents and EPS of 1.60 cents.
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 3.20 cents.

SDV STOCK CHART